Xr Securities LLC Biogen Inc. Transaction History

Xr Securities LLC

$342 Million
Q3 2024

A detailed history of Xr Securities LLC transactions in Biogen Inc. stock. As of the latest transaction made, Xr Securities LLC holds 1,500 shares of BIIB stock, worth $260,685. This represents 0.08% of its overall portfolio holdings.

Number of Shares

1,500

Previous 1,500 -0.0%

Holding current value

$260,685

Previous $347,000 16.43%

% of portfolio

0.08%

Previous 0.06%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$256.56 - $292.34 $831,510 - $947,473	-3,241 Reduced 74.28%	1,122 $311,000
Q4 2022 Jan 03, 2023	BUY	$252.44 - $306.72 $1.1 Million - $1.34 Million	4,363 New	4,363 $1.21 Million
Q2 2022 Jul 14, 2022	SELL	$187.54 - $223.02 $51,198 - $60,884	-273 Reduced 10.24%	2,393 $488,000
Q1 2022 Apr 14, 2022	BUY	$193.77 - $244.14 $327,277 - $412,352	1,689 Added 172.88%	2,666 $561,000
Q4 2021 Jan 10, 2022	BUY	$223.92 - $287.77 $11,196 - $14,388	50 Added 5.39%	977 $234,000
Q1 2021 Apr 29, 2021	BUY	$242.95 - $284.63 $225,214 - $263,852	927 New	927 $259,000
Q3 2020 Oct 28, 2020	SELL	$264.77 - $305.71 $943,110 - $1.09 Million	-3,562 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $921,346 - $1.22 Million	3,562 New	3,562 $953,000
Q1 2020 Apr 09, 2020	SELL	$268.85 - $341.04 $1.51 Million - $1.91 Million	-5,598 Closed	0 $0
Q4 2019 Jan 06, 2020	SELL	$220.06 - $304.07 $538,926 - $744,667	-2,449 Reduced 30.43%	5,598 $1.66 Million
Q3 2019 Oct 03, 2019	BUY	$217.44 - $243.88 $820,183 - $919,915	3,772 Added 88.23%	8,047 $1.87 Million
Q2 2019 Jul 10, 2019	BUY	$219.29 - $241.72 $626,072 - $690,110	2,855 Added 201.06%	4,275 $1 Million
Q3 2018 Oct 04, 2018	BUY	$293.51 - $383.83 $416,784 - $545,038	1,420 New	1,420 $502,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Xr Securities LLC with notifications on news.

Account

Xr Securities LLC Biogen Inc. Transaction History